Clinical study for the evaluation of the safety and efficacy of masitinib in patients suffering from parkinson's disease Clinical study for the evaluation of the safety and efficacy of masitinibin patients suffering from ...
A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel group, phase 2 study to compare the efficacy and safety of masitinib versus placebo on cognitive impairment associated with Parkinson's disease A prospective, multicenter, randomised, double-blind, placebo-controlled, parallel group, phase 2 st ...
Parkinson's disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Parkinson's disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...